Publications by authors named "Angelo Cattaneo"

Claim this Profile
N
Non-pustular primary annular plaque-type psoriasis.
Italo F Aromolo, Lorenzo Rocca, Chiara Benaglia, Domenico Simeoli, Gabriele Perego, Angelo Cattaneo

Ital J Dermatol Venerol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new instrument for the screening of psoriatic arthritis among psoriatic patients.
Gabriele De Marco, Antonio Marchesoni, Maria Manara, Paolo Gisondi, Luca Idolazzi, Angelo Cattaneo

Clin Exp Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, Laura Atzori, Anna Balato, Angelo Cattaneo

Dermatol Ther (Heidelb)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belimumab-induced periungual pyogenic granulomas: A case report.
Cecilia Beatrice Chighizola, Ilaria Suardi, Achille Marino, Maurizio Gattinara, Stefania Costi, Angelo Cattaneo

Lupus· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antinuclear matrix protein 2 antibody-positive dermatomyositis: a rare entity.
Martina Zussino, Carlo A Maronese, Gaia Montanelli, Francesca L Boggio, Chiara Moltrasio, Angelo Cattaneo

Ital J Dermatol Venerol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telangiectatic Macules Spreading During More Than 30 Years: A Quiz.
Italo Francesco Aromolo, Eleonora Di Michele, Francesca Laura Boggio, Angelo Cattaneo, Angelo Valerio Marzano

Acta Derm Venereol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Filomena Russo, Marco Galluzzo, Luca Stingeni, Severino Persechino, Leonardo Zichichi, Angelo Cattaneo

Clin Cosmet Investig Dermatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review.
Nerina Denaro, Gianluca Nazzaro, Giulia Murgia, Federica Scarfì, Carolina Cauchi, Angelo Cattaneo

Int J Mol Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphic rupioid psoriasis with chamomile-like lesions: A case report.
Italo Francesco Aromolo, Davide Riva, Angelo Cattaneo, Carlo Giovanni Carrera, Cristina Beatrice Spigariolo

J Eur Acad Dermatol Venereol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.
Marina Talamonti, Filomena Russo, Giovanna Malara, Katharina Hansel, Manuela Papini, Angelo Cattaneo

Clin Cosmet Investig Dermatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
Cristina B Spigariolo, Francesca Barei, Carlo A Maronese, Francesco Barberi, Angelo Cattaneo

Australas J Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter".
Giulia Murgia, Carlo Alberto Maronese, Carlo Giovanni Carrera, Angelo Cattaneo, Angelo Valerio Marzano

Dermatol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Centre Real-Life Experience of Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis.
Dario Marletta, Giulia Murgia, Angelo Cattaneo, Carlo Carrera, Angelo Marzano

J Drugs Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab.
Maurizio Romagnuolo, Simona Muratori, Angelo Cattaneo, Angelo Valerio Marzano, Chiara Moltrasio

Dermatol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faint pigment network in atypical vascular proliferation of the breast: A potential dermoscopic pitfall.
Carlo A Maronese, Francesca L Boggio, Francesco Barberi, Maurizio Romagnuolo, Davide Riva, Angelo Cattaneo

Australas J Dermatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations.
Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, Stefano Piaserico, Paolo Amerio, Angelo Cattaneo

Dermatol Ther (Heidelb)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Secukinumab Fast-Responder Profile in Psoriatic Patients: Advanced Application of Artificial-Neural-Networks (ANNs).
Giovanni Damiani, Rosalynn R Z Conic, Paolo D M Pigatto, Carlo G Carrera, Chiara Franchi, Angelo Cattaneo

J Drugs Dermatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mysterious abdominal pain during active psoriasis.
Valentina Della Valle, Marco Maggioni, Carlo Carrera, Angelo Cattaneo, Angelo Valerio Marzano

Intern Emerg Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis.
Carlo Giovanni Carrera, Paolo Dapavo, Piergiorgio Malagoli, Luigi Naldi, Luisa Arancio, Angelo Cattaneo

J Dermatolog Treat· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EPIPSOFIRE project: a preliminary report.
Gabriele De Marco, Angelo Cattaneo, Carlo G Carrera, Patrizia Gibertini, Norma Battafarano

Drug Dev Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients.
Gabriele De Marco, Angelo Cattaneo, Norma Battafarano, Ennio Lubrano, Carlo G Carrera

Arch Dermatol Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tomesa balneophototherapy in mild to severe psoriasis: a retrospective clinical trial in 174 patients.
Angelo Cattaneo, Silvia Alberti Violetti, Simona Tavecchio, Elena Bruni, Carlo Carrera

Photodermatol Photoimmunol Photomed· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis